Our expertise
Overview
Our world-class team of 75+ people bring together a depth and breadth of knowledge born from years of practical experience in the seamless scale-up of technology for manufacturing. Many of the team came from our parent company, Univercells which has a 10-year track record in biomanufacturing.
Our Research Center located in France=> expertise into the development of the most robust and scalable DNA synthesis technology using a specifically engineered high-performance enzyme with the advantages of:
One-step generation of long fragments with no maximum length
Up to 10000-fold more quantity generated
High-fidelity synthesis of any sequence, regardless of GC content
Products that are already 99% pure requiring no downstream purification for most applications
GMP compatible process
To support our mission of removing the barriers to making mRNA-based vaccines, our international team is composed of experts with competencies ranging from in-silico to in-vivo experimental studies and analytical tools. Our brilliant minds have strong and complementary backgrounds in molecular and structural biology, process development, equipment engineering, qualification and validation, product development, and more.
Quantoom has built a highly-skilled team of international experts to develop NcapsulateTM, our RNA formulation system. The team can manage the development, screening and optimization of lipid nanoparticle (LNP) and polymer-based formulations for RNA delivery. We can also provide physicochemical, in vitro and in vivo characterization, including biodistribution and immune challenge for prophylactic vaccine application of RNA delivery systems. We provide services for the development of the entire RNA formulation process and manufacturing system.
Based on fundamental engineering principles, the idea is to intensify and introduce repeated-batch production. This significantly reduces the footprint for easy transportation and optimization of cleanroom space. Manual steps are reduced which improves safety and product quality By advancing RNA production technologies, Quantoom will drastically reduce production costs and improve the availability of life-saving biologics. Technology-driven affordability will enable sustainable pharma production in Wallonia at competitive prices and encourage global product export.
